{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:40:53Z","timestamp":1775673653690,"version":"3.50.1"},"reference-count":129,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>It has been estimated that 80% of the pre-mRNA undergoes alternative splicing, which exponentially increases the flow of biological information in cellular processes and can be an attractive therapeutic target. It is a crucial mechanism to increase genetic diversity. Disturbed alternative splicing is observed in many disorders, including neuromuscular diseases and carcinomas. Spinal Muscular Atrophy (SMA) is an autosomal recessive neurodegenerative disease. Homozygous deletion in 5q13 (the region coding for the motor neuron survival gene (SMN1)) is responsible for 95% of SMA cases. The nearly identical SMN2 gene does not compensate for SMN loss caused by SMN1 gene mutation due to different splicing of exon 7. A pathologically low level of survival motor neuron protein (SMN) causes degeneration of the anterior horn cells in the spinal cord with associated destruction of \u03b1-motor cells and manifested by muscle weakness and loss. Understanding the regulation of the SMN2 pre-mRNA splicing process has allowed for innovative treatment and the introduction of new medicines for SMA. After describing the concept of splicing modulation, this review will cover the progress achieved in this field, by highlighting the breakthrough accomplished recently for the treatment of SMA using the mechanism of alternative splicing.<\/jats:p>","DOI":"10.3390\/genes12091346","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T21:45:16Z","timestamp":1630273516000},"page":"1346","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy"],"prefix":"10.3390","volume":"12","author":[{"given":"Jan","family":"Lejman","sequence":"first","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-0641","authenticated-orcid":false,"given":"Grzegorz","family":"Zieli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Sports Medicine, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-9960","authenticated-orcid":false,"given":"Piotr","family":"Gawda","sequence":"additional","affiliation":[{"name":"Department of Sports Medicine, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lejman","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-MRNA Splicing and Human Disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev."},{"key":"ref_2","first-page":"612","article-title":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ymeth.2013.08.019","article-title":"Systematical Identification of Splicing Regulatory Cis-Elements and Cognate Trans-Factors","volume":"65","author":"Wang","year":"2014","journal-title":"Methods"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"194395","DOI":"10.1016\/j.bbagrm.2019.06.006","article-title":"More than a Messenger: Alternative Splicing as a Therapeutic Target","volume":"1862","author":"Black","year":"2019","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tig.2018.10.002","article-title":"RNA Splicing and Disease: Animal Models to Therapies","volume":"35","author":"Montes","year":"2019","journal-title":"Trends Genet. TIG"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1074\/jbc.RA118.003392","article-title":"Distinct Mechanisms Govern the Phosphorylation of Different SR Protein Splicing Factors","volume":"294","author":"Long","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2009.02.011","article-title":"RNA and Disease","volume":"136","author":"Cooper","year":"2009","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Seo, J., Singh, N.N., Ottesen, E.W., Sivanesan, S., Shishimorova, M., and Singh, R.N. (2016). Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154390"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/acel.12646","article-title":"The Emerging Role of Alternative Splicing in Senescence and Aging","volume":"16","author":"Chabot","year":"2017","journal-title":"Aging Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1016\/j.celrep.2019.11.093","article-title":"Dysregulation of RNA Splicing in Tauopathies","volume":"29","author":"Apicco","year":"2019","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-018-06448-y","article-title":"Disrupted Alternative Splicing for Genes Implicated in Splicing and Ciliogenesis Causes PRPF31 Retinitis Pigmentosa","volume":"9","author":"Buskin","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10571-019-00717-0","article-title":"Alternative Splicing of ALS Genes: Misregulation and Potential Therapies","volume":"40","author":"Perrone","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/humu.20087","article-title":"Familial Adenomatous Polyposis: Aberrant Splicing Due to Missense or Silent Mutations in the APC Gene","volume":"24","author":"Aretz","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_14","first-page":"4051","article-title":"Prader-Willi Locus Snord116 RNA Processing Requires an Active Endogenous Allele and Neuron-Specific Splicing by Rbfox3\/NeuN","volume":"27","author":"Coulson","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jmcb\/mjz033","article-title":"Aberrant Alternative Splicing in Breast Cancer","volume":"11","author":"Yang","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"145262","DOI":"10.1016\/j.gene.2020.145262","article-title":"Next-Generation Sequencing Reveals Alternative L-DOPA Decarboxylase (DDC) Splice Variants Bearing Novel Exons, in Human Hepatocellular and Lung Cancer Cells","volume":"768","author":"Papatsirou","year":"2021","journal-title":"Gene"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, T.-H. (2020). New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093297"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archneur.1971.00490030102014","article-title":"Two Early Infantile Hereditary Cases of Progressive Muscular Atrophy Simulating Dystrophy, but on a Neural Basis. 1891","volume":"25","author":"Werdnig","year":"1971","journal-title":"Arch. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01668496","article-title":"Ueber chronische spinale Muskelatrophie im Kindesalter, auf famili\u00e4rer Basis","volume":"3","author":"Hoffmann","year":"1893","journal-title":"Dtsch. Z. Nervenheilkd."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, Incidence and Carrier Frequency of 5q\u2013Linked Spinal Muscular Atrophy\u2014A Literature Review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_21","unstructured":"Burr, P., and Reddivari, A.K.R. (2021). Spinal Muscle Atrophy. StatPearls, StatPearls Publishing."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The Neurobiology of Childhood Spinal Muscular Atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/01.wnl.0000172860.41953.12","article-title":"Evidence of Reduced Frequency of Spinal Muscular Atrophy Type I in the Cuban Population","volume":"65","author":"Montejo","year":"2005","journal-title":"Neurology"},{"key":"ref_24","unstructured":"(2021, May 24). Jak Cz\u0119ste Jest SMA? Fund SMA. Available online: https:\/\/www.fsma.pl\/rdzeniowy-zanik-miesni\/jak-czeste-jest-sma\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5603\/PJNNS.a2019.0068","article-title":"Spinal Muscular Atrophy\u2014New Therapies, New Challenges","volume":"54","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and Characterization of a Spinal Muscular Atrophy-Determining Gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","article-title":"Mutation Update of Spinal Muscular Atrophy in Spain: Molecular Characterization of 745 Unrelated Patients and Identification of Four Novel Mutations in the SMN1 Gene","volume":"125","author":"Bernal","year":"2009","journal-title":"Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/4.8.1273","article-title":"Allelic Association and Deletions in Autosomal Recessive Proximal Spinal Muscular Atrophy: Association of Marker Genotype with Disease Severity and Candidate CDNAs","volume":"4","author":"Wirth","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.33.4.281","article-title":"Large Scale Deletions of the 5q13 Region Are Specific to Werdnig-Hoffmann Disease","volume":"33","author":"Burlet","year":"1996","journal-title":"J. Med. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/hmg\/5.2.257","article-title":"Molecular Analysis of the SMN and NAIP Genes in Spanish Spinal Muscular Atrophy (SMA) Families and Correlation between Number of Copies of CBCD541 and SMA Phenotype","volume":"5","author":"Velasco","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.33.2.93","article-title":"Gene Deletions in Spinal Muscular Atrophy","volume":"33","author":"Rodrigues","year":"1996","journal-title":"J. Med. Genet."},{"key":"ref_32","first-page":"72","article-title":"The Gene Encoding P44, a Subunit of the Transcription Factor TFIIH, Is Involved in Large-Scale Deletions Associated with Werdnig-Hoffmann Disease","volume":"60","author":"Seroz","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/6.2.229","article-title":"A Multicopy Transcription-Repair Gene, BTF2p44, Maps to the SMA Region and Demonstrates SMA Associated Deletions","volume":"6","author":"Carter","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3988\/jcn.2017.13.1.27","article-title":"Genotype-Phenotype Correlation of SMN1 and NAIP Deletions in Korean Patients with Spinal Muscular Atrophy","volume":"13","author":"Ahn","year":"2017","journal-title":"J. Clin. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal Muscular Atrophy: A Timely Review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival Motor Neuron Gene 2 Silencing by DNA Methylation Correlates with Spinal Muscular Atrophy Disease Severity and Can Be Bypassed by Histone Deacetylase Inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/0883073807305666","article-title":"Molecular Functions of the SMN Complex","volume":"22","author":"Kolb","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal Muscular Atrophy","volume":"6","author":"Mercuri","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1242\/dmm.030148","article-title":"Therapeutic Strategies for Spinal Muscular Atrophy: SMN and Beyond","volume":"10","author":"Bowerman","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mgg3.141","article-title":"SMN1 and SMN2 Copy Numbers in Cell Lines Derived from Patients with Spinal Muscular Atrophy as Measured by Array Digital PCR","volume":"3","author":"Stabley","year":"2015","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases","volume":"3","author":"Butchbach","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3389\/fmicb.2017.02252","article-title":"A Multilayered Control of the Human Survival Motor Neuron Gene Expression by Alu Elements","volume":"8","author":"Ottesen","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00439-017-1835-2","article-title":"SMN Regulation in SMA and in Response to Stress: New Paradigms and Therapeutic Possibilities","volume":"136","author":"Dominguez","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/hmg\/ddy195","article-title":"Temporal and Tissue-Specific Variability of SMN Protein Levels in Mouse Models of Spinal Muscular Atrophy","volume":"27","author":"Groen","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/14728222.2020.1783241","article-title":"RNA in Spinal Muscular Atrophy: Therapeutic Implications of Targeting","volume":"24","author":"Singh","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1884910","article-title":"A Degron Created by SMN2 Exon 7 Skipping Is a Principal Contributor to Spinal Muscular Atrophy Severity","volume":"24","author":"Cho","year":"2010","journal-title":"Genes Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1038\/s41598-020-67569-3","article-title":"Nusinersen Ameliorates Motor Function and Prevents Motoneuron Cajal Body Disassembly and Abnormal Poly(A) RNA Distribution in a SMA Mouse Model","volume":"10","author":"Berciano","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1073\/pnas.160181697","article-title":"Htra2-Beta 1 Stimulates an Exonic Splicing Enhancer and Can Restore Full-Length SMN Expression to Survival Motor Neuron 2 (SMN2)","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wee, C.D., Havens, M.A., Jodelka, F.M., and Hastings, M.L. (2014). Targeting SR Proteins Improves SMN Expression in Spinal Muscular Atrophy Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115205"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/emboj.2010.19","article-title":"The Splicing Regulator Sam68 Binds to a Novel Exonic Splicing Silencer and Functions in SMN2 Alternative Splicing in Spinal Muscular Atrophy","volume":"29","author":"Pedrotti","year":"2010","journal-title":"EMBO J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/gt.2017.34","article-title":"How the Discovery of ISS-N1 Led to the First Medical Therapy for Spinal Muscular Atrophy","volume":"24","author":"Singh","year":"2017","journal-title":"Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1128\/MCB.22.12.4001-4010.2002","article-title":"SRp30c Is a Repressor of 3\u2019 Splice Site Utilization","volume":"22","author":"Simard","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","article-title":"Characterizing the RNA Targets and Position-Dependent Splicing Regulation by TDP-43","volume":"14","author":"Tollervey","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molcel.2018.01.011","article-title":"The TIA1 RNA-Binding Protein Family Regulates EIF2AK2-Mediated Stress Response and Cell Cycle Progression","volume":"69","author":"Meyer","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/MCB.01332-08","article-title":"The RNA Binding Protein HnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (SMN2) Gene","volume":"28","author":"Chen","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1093\/nar\/gku244","article-title":"Characterization of the RNA Recognition Mode of HnRNP G Extends Its Role in SMN2 Splicing Regulation","volume":"42","author":"Moursy","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Tang, Z., Zhao, J., Pearson, Z.J., Boskovic, Z.V., and Wang, J. (2021). RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays. Molecules, 26.","DOI":"10.3390\/molecules26082263"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/nar\/gkl1050","article-title":"Modulating Role of RNA Structure in Alternative Splicing of a Critical Exon in the Spinal Muscular Atrophy Genes","volume":"35","author":"Singh","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41467-018-04110-1","article-title":"Targeting RNA Structure in SMN2 Reverses Spinal Muscular Atrophy Molecular Phenotypes","volume":"9","author":"Tessaro","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron","volume":"26","author":"Singh","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-89689-2_2","article-title":"Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes","volume":"20","author":"Singh","year":"2018","journal-title":"Adv. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/humu.24149","article-title":"Identification of SRSF10 as a Regulator of SMN2 ISS-N1","volume":"42","author":"Frederiksen","year":"2021","journal-title":"Hum. Mutat."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4161\/rna.6.3.8723","article-title":"A Short Antisense Oligonucleotide Masking a Unique Intronic Motif Prevents Skipping of a Critical Exon in Spinal Muscular Atrophy","volume":"6","author":"Singh","year":"2009","journal-title":"RNA Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1038\/mtna.2014.23","article-title":"A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy","volume":"3","author":"Keil","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"194403","DOI":"10.1016\/j.bbagrm.2019.07.004","article-title":"How RNA Structure Dictates the Usage of a Critical Exon of Spinal Muscular Atrophy Gene","volume":"1862","author":"Singh","year":"2019","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1261\/rna.2154310","article-title":"An Antisense Microwalk Reveals Critical Role of an Intronic Position Linked to a Unique Long-Distance Interaction in Pre-MRNA Splicing","volume":"16","author":"Singh","year":"2010","journal-title":"RNA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1093\/nar\/gkt609","article-title":"An Intronic Structure Enabled by a Long-Distance Interaction Serves as a Novel Target for Splicing Correction in Spinal Muscular Atrophy","volume":"41","author":"Singh","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23271","DOI":"10.1074\/jbc.M200851200","article-title":"Identification of a Cis-Acting Element for the Regulation of SMN Exon 7 Splicing","volume":"277","author":"Miyajima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2016.145","article-title":"Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy","volume":"24","author":"Osman","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15252\/emmm.201607199","article-title":"Delivery Is Key: Lessons Learnt from Developing Splice-Switching Antisense Therapies","volume":"9","author":"Godfrey","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense Oligonucleotides","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurol. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-Switching Antisense Oligonucleotides as Therapeutic Drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20966\/chn.2018.55.429","article-title":"Molecular Basis and Therapy of Spinal Muscular Atrophy","volume":"27","author":"Szczerba","year":"2019","journal-title":"Child Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.32383\/farmpol\/118343","article-title":"Spinal Muscular Atrophy\u2014Onasemnogene Abeparvovec and Other Therapeutic Options","volume":"76","author":"Warych","year":"2020","journal-title":"Farm. Pol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18388\/abp.2009_2521","article-title":"Phenotype Modifiers of Spinal Muscular Atrophy: The Number of SMN2 Gene Copies, Deletion in the NAIP Gene and Probably Gender Influence the Course of the Disease","volume":"56","author":"Jedrzejowska","year":"2009","journal-title":"Acta Biochim. Pol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense Correction of SMN2 Splicing in the CNS Rescues Necrosis in a Type III SMA Mouse Model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dmcn.14027","article-title":"Nusinersen Treatment of Spinal Muscular Atrophy: Current Knowledge and Existing Gaps","volume":"61","author":"Gidaro","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3349\/ymj.2020.61.4.273","article-title":"Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy","volume":"61","author":"Li","year":"2020","journal-title":"Yonsei Med. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s12325-019-00923-8","article-title":"Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1","volume":"36","author":"Dabbous","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_80","unstructured":"(2018). Spinraza (Nusinersen), Biogen Inc.. Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/209531lbl.pdf."},{"key":"ref_81","first-page":"S3","article-title":"Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease","volume":"24","author":"Rao","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1093\/hmg\/ddx215","article-title":"Spinal Muscular Atrophy: Antisense Oligonucleotide Therapy Opens the Door to an Integrated Therapeutic Landscape","volume":"26","author":"Wood","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/jisprm.jisprm_4_19","article-title":"Rehabilitation in Spinal Muscular Atrophy","volume":"2","author":"Foead","year":"2019","journal-title":"J. Int. Soc. Phys. Rehabil. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00415-020-10223-9","article-title":"Nusinersen Treatment Significantly Improves Hand Grip Strength, Hand Motor Function and MRC Sum Scores in Adult Patients with Spinal Muscular Atrophy Types 3 and 4","volume":"268","author":"Goosens","year":"2021","journal-title":"J. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/nyas.12727","article-title":"Splicing Regulation in Spinal Muscular Atrophy by an RNA Structure Formed by Long-Distance Interactions","volume":"1341","author":"Singh","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a Phase 1 Study of Nusinersen (ISIS-SMNRx) in Children with Spinal Muscular Atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ymthe.2017.03.036","article-title":"Gender-Specific Amelioration of SMA Phenotype upon Disruption of a Deep Intronic Structure by an Oligonucleotide","volume":"25","author":"Howell","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1038\/s41598-017-03850-2","article-title":"LNA\/DNA Mixmer-Based Antisense Oligonucleotides Correct Alternative Splicing of the SMN2 Gene and Restore SMN Protein Expression in Type 1 SMA Fibroblasts","volume":"7","author":"Touznik","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2018.01.011","article-title":"Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript","volume":"11","author":"Flynn","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen Initiated in Infants during the Presymptomatic Stage of Spinal Muscular Atrophy: Interim Efficacy and Safety Results from the Phase 2 NURTURE Study","volume":"29","author":"Bertini","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor Neuron Disease. SMN2 Splicing Modifiers Improve Motor Function and Longevity in Mice with Spinal Muscular Atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymeth.2019.06.011","article-title":"Splice-Switching Small Molecules: A New Therapeutic Approach to Modulate Gene Expression","volume":"167","author":"Campbell","year":"2019","journal-title":"Methods"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-017-01559-4","article-title":"Binding to SMN2 Pre-MRNA-Protein Complex Elicits Specificity for Small Molecule Splicing Modifiers","volume":"8","author":"Sivaramakrishnan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s40265-020-01410-z","article-title":"Risdiplam: First Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e00447","DOI":"10.1002\/prp2.447","article-title":"Risdiplam Distributes and Increases SMN Protein in Both the Central Nervous System and Peripheral Organs","volume":"6","author":"Poirier","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.32383\/farmpol\/115754","article-title":"Therapeutic Targeting of Alternative Splicing","volume":"75","author":"Paluszczak","year":"2019","journal-title":"Farm. Pol."},{"key":"ref_99","first-page":"E4604","article-title":"Mechanistic Studies of a Small-Molecule Modulator of SMN2 Splicing","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in Type 1 Spinal Muscular Atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Singh, R.N., Ottesen, E.W., and Singh, N.N. (2020). The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy. Neurosci. Insights, 15.","DOI":"10.1177\/2633105520973985"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Messina, S., and Sframeli, M. (2020). New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072222"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","article-title":"Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease","volume":"109","author":"Yeo","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal Muscular Atrophy: Going beyond the Motor Neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_105","unstructured":"(2021, July 07). Evrysdi (Risdiplam) FDA Approval History. Available online: https:\/\/www.drugs.com\/history\/evrysdi.html."},{"key":"ref_106","unstructured":"Novartis Pharmaceuticals (2021, June 28). An Open Label Multi-Part First-in-Human Study of Oral LMI070 in Infants with Type 1 Spinal Muscular Atrophy, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02268552."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 Splice Modulators Enhance U1-Pre-MRNA Association and Rescue SMA Mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"17472","DOI":"10.1038\/s41598-020-74346-9","article-title":"Discovery of a CNS Penetrant Small Molecule SMN2 Splicing Modulator with Improved Tolerability for Spinal Muscular Atrophy","volume":"10","author":"Ando","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1261\/rna.7580704","article-title":"In Vivo Selection Reveals Combinatorial Controls That Define a Critical Exon in the Spinal Muscular Atrophy Genes","volume":"10","author":"Singh","year":"2004","journal-title":"RNA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.2741\/2310","article-title":"Unfolding the Mystery of Alternative Splicing through a Unique Method of in Vivo Selection","volume":"12","author":"Singh","year":"2007","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1021\/acs.jmedchem.6b00460","article-title":"Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy","volume":"59","author":"Woll","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/hmg\/ddw062","article-title":"Pharmacokinetics, Pharmacodynamics, and Efficacy of a Small-Molecule SMN2 Splicing Modifier in Mouse Models of Spinal Muscular Atrophy","volume":"25","author":"Zhao","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1021\/acs.jmedchem.6b00459","article-title":"Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy","volume":"59","author":"Ratni","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acs.jmedchem.7b00406","article-title":"Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy","volume":"60","author":"Pinard","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1021\/acs.jmedchem.8b01291","article-title":"Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)","volume":"61","author":"Cheung","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nmd.2018.10.001","article-title":"The Oral Splicing Modifier RG7800 Increases Full Length Survival of Motor Neuron 2 MRNA and Survival of Motor Neuron Protein: Results from Trials in Healthy Adults and Patients with Spinal Muscular Atrophy","volume":"29","author":"Kletzl","year":"2019","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bcp.13786","article-title":"A Phase 1 Healthy Male Volunteer Single Escalating Dose Study of the Pharmacokinetics and Pharmacodynamics of Risdiplam (RG7916, RO7034067), a SMN2 Splicing Modifier","volume":"85","author":"Sturm","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_118","first-page":"3021","article-title":"Drosophila SMN2 Minigene Reporter Model Identifies Moxifloxacin as a Candidate Therapy for SMA","volume":"34","author":"Konieczny","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","article-title":"Specific Inhibition of Myostatin Activation Is Beneficial in Mouse Models of SMA Therapy","volume":"28","author":"Long","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12542","article-title":"Myostatin Inhibition in Combination with Antisense Oligonucleotide Therapy Improves Outcomes in Spinal Muscular Atrophy","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_121","unstructured":"Cytokinetics (2021, August 17). A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02644668."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA Type and SMN2 Copy Number Revisited: An Analysis of 625 Unrelated Spanish Patients and a Compilation of 2834 Reported Cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","article-title":"Spinal Muscular Atrophy: A Changing Phenotype beyond the Clinical Trials","volume":"27","author":"Tizzano","year":"2017","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddx166","article-title":"A-44G Transition in SMN2 Intron 6 Protects Patients with Spinal Muscular Atrophy","volume":"26","author":"Wu","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a Potential Biomarker for Spinal Muscular Atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and Management of Spinal Muscular Atrophy: Part 1: Recommendations for Diagnosis, Rehabilitation, Orthopedic and Nutritional Care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and Management of Spinal Muscular Atrophy: Part 2: Pulmonary and Acute Care; Medications, Supplements and Immunizations; Other Organ Systems; and Ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul. Disord. NMD"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/9\/1346\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:39Z","timestamp":1760165679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/9\/1346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":129,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["genes12091346"],"URL":"https:\/\/doi.org\/10.3390\/genes12091346","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]}}}